Author:
Wu Yiqun,Hu Yonghua,Tang Xun,He Liu,Ren Tao,Tao Qiushan,Qin Xueying,Sun Ningling,Wang Hongyi,Cao Weihua,Wu Tao,Zhan Siyan,Wang Jin,Chen Weihua,Li Liming
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference23 articles.
1. Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005 Sep; 366(9489): 895–906
2. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004 Jun; 363(9426): 2022–31
3. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008 Dec; 359(23): 2417–28
4. Destro M, Cagnoni F, D’Ospina A, et al. New strategies and drugs in the treatment of hypertension: monotherapy or combination? Recent Pat Cardiovasc Drug Discov 2010 Jan; 5(1): 69–81
5. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007 Jun; 28(1): 1462–536
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献